Home / PPOX Knockout Cell Lines

PPOX Knockout Cell Lines

Gene: PPOX

Official Full Name: protoporphyrinogen oxidaseprovided by HGNC

Gene Summary: This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO35948 PPOX Knockout cell line (HeLa) Human PPOX 1:3~1:6 Negative Online Inquiry
KO35949 PPOX Knockout cell line (HCT 116) Human PPOX 1:2~1:4 Negative Online Inquiry
KO35950 PPOX Knockout cell line (HEK293) Human PPOX 1:3~1:6 Negative Online Inquiry
KO35951 PPOX Knockout cell line (A549) Human PPOX 1:3~1:4 Negative Online Inquiry

Background

PPOX Gene Knockout Cell Lines are specifically engineered cellular models that lack the expression of the protoporphyrinogen oxidase (PPOX) gene, which plays a crucial role in the heme biosynthesis pathway. These knockout cell lines are invaluable tools for studying porphyrias, particularly variegate porphyria, where the dysfunctional PPOX enzyme leads to an accumulation of porphyrin precursors and subsequently contributes to various pathological conditions. By utilizing these cell lines, researchers can investigate the underlying molecular mechanisms that contribute to porphyria and explore potential therapeutic interventions.

The primary function of PPOX Gene Knockout Cell Lines lies in their ability to mimic disease states, providing a platform for examining phenotypic changes associated with the absence of the PPOX gene. Researchers can elucidate the metabolic disruptions that result from this knockout, allowing for a deeper understanding of the disease processes involved. Additionally, these lines facilitate high-throughput screening of pharmacological agents aimed at correcting the metabolic derangements caused by PPOX deficiency.

The significance of these cell lines extends beyond basic research; they are also pivotal in the development of targeted therapies and gene editing technologies. Their application in clinical settings can lead to novel therapeutic strategies for managing porphyrias and developing gene therapies that restore normal function.

Compared to conventional models, PPOX Gene Knockout Cell Lines present distinct advantages, such as the ability to study specific gene functions in human-derived tissues, reduced variability among experimental results, and greater relevance to human disease. Furthermore, the ease of manipulation and adaptability to various experimental conditions make them highly advantageous for both in vitro and in vivo studies.

For researchers and clinicians focusing on metabolic disorders, these cell lines are not just a research tool; they are a gateway to understanding complex biochemical pathways and developing innovative treatments. By investing in our PPOX Gene Knockout Cell Lines, users gain access to a cutting-edge resource backed by our company’s extensive expertise in biological product development and commitment to advancing scientific discovery. Our team is dedicated to supporting researchers in their quest to unravel the complexities of genetic diseases and forge new paths toward effective therapies.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.